PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease

PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease

Bibliographic Details
Main Authors:	Keshav, S, Petryka, R, Vanask, T, Niv, Y, Marlicz, K, Haagen-Nielsen, O, Machado, M, Dahlerup, J, Schreiber, S, Bekker, P, Sankar, S, Schall, T
Format:	Conference item
Published:	2007

Similar Items

Protect-1, a prospective randomized oral therapy evaluation of CCX282-B (Traficet-EN) in Crohn's disease trial
by: Bekker, P, et al.
Published: (2008)

Traficet-EN (CCX282-B), an orally active inhibitor of chemokine receptor CCR9, for treatment of Crohn's disease
by: Bekker, P, et al.
Published: (2007)

PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease
by: Bekker, P, et al.
Published: (2009)

PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease
by: Keshav, S, et al.
Published: (2009)

Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease
by: Keshav, S, et al.
Published: (2007)

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.
by: Walters, M, et al.
Published: (2010)

Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease
by: Bekker, P, et al.
Published: (2008)

Traficet-EN, an Oral CCR9-Specific Antagonist, induces high levels of remission in the open-label Phase of PROTECT-1 in Crohn's Disease
by: Bekker, P, et al.
Published: (2008)

MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B
by: Ungashe, S, et al.
Published: (2008)

Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis
by: Wei, Z, et al.
Published: (2005)

Chemokines and myeloid cell recruitment.
by: Greaves, D, et al.
Published: (2000)

Abduction of chemokine elements by herpesviruses
by: Dairaghi, D, et al.
Published: (1998)

Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
by: Adams, P, et al.
Published: (2018)

CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.
by: Kathleen M C Sullivan, et al.
Published: (2023-01-01)

Expression of CCR8 and CCX-CKR on Basophils in Chronic Urticaria Is Amplified by IgE-Mediated Activation
by: Ewa A. Bartko, et al.
Published: (2023-05-01)

Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis
by: Baatrup Gunnar, et al.
Published: (2005-09-01)

Medical management of Crohn's disease.
by: Cummings, JR, et al.
Published: (2008)

Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease
by: Bekker, P, et al.
Published: (2007)

Mat 282- Pengiraan Kejuruteraan I
by: PPSM, Pusat Pengajian Sains Matematik
Published: (2004)

Contribuíram nesta edição (28.2)
Published: (2020-06-01)

Contribuíram nesta edição (28.2)
Published: (2020-06-01)

High-Pressure Cooling in Finishing Turning of Haynes 282 Using Carbide Tools: Haynes 282 and Inconel 718 Comparison
by: Antonio Díaz-Álvarez, et al.
Published: (2021-11-01)

282 COLPOSUSPENSION, DOES SUTURE MATERIAL MATTER?
by: S Kay, et al.
Published: (2022-06-01)

Draft genome sequence of the model naphthalene-utilizing organism Pseudomonas putida OUS282
by: Tay, Martin, et al.
Published: (2019)

ZAE 282/3 - SAINS BAHAN SEPT 1997.
by: PPSF, Pusat Pengajian Sains Fizik
Published: (1997)

ZAE282-3 - MATERIAL SCIENCES - NOVEMBER 2008.
by: PPSF, Pusat Pengajian Sains Fizik
Published: (2008)

MAT 282 - Engineering Computation I November 2006
by: PPSM, Pusat Pengajian Sains Matematik
Published: (2006)

MAT 282 - Pengiraan Kejuruteraan I - Oktober 2004
by: PPSM, Pusat Pengajian Sains Matematik
Published: (2004)

Genomic characteristics of an avipoxvirus 282E4 strain
by: Lingcong Deng, et al.
Published: (2023-10-01)

Chemokines, chemokine receptors and atherosclerosis
by: John, A, et al.
Published: (2005)

Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y
by: James C. Barton, et al.
Published: (2023-04-01)

Platelet counts in HFE p.C282Y/p.C282Y and wt/wt post-screening clinical evaluation participants
by: James C. Barton, et al.
Published: (2023-12-01)

Chemokines and chemokine receptors in Behçet’s disease
by: Zhan Li, et al.
Published: (2023-01-01)

Pathophysiological role of chemokine MIG/CXCL9 in the development of atopic dermatitis
by: I. V. Kibalina, et al.
Published: (2022-05-01)

PCSK9 Imperceptibly Affects Chemokine Receptor Expression In Vitro and In Vivo
by: Sai Sahana Sundararaman, et al.
Published: (2021-12-01)

Paneth cells in Crohn's disease - Effect of NOD2/CARD15 variants
by: Abeya, M, et al.
Published: (2004)

ZAE 282E/3 - SAINS BAHAN SEP 03.
by: PPSF, Pusat Pengajian Sains Fizik
Published: (2003)

ZAE 282E-3 - MATERIAL SCIENCE OCT 2004
by: PPSF, Pusat Pengajian Sains Fizik
Published: (2004)

MAT 282 - Pengiraan Kejuruteraan 1 (September/Oktober 2003)
by: PPSM, Pusat Pengajian Sains Matematik
Published: (2003)

ZAE 282E/3 - MATERIAL SCIENCE OKT 04
by: PPSF, Pusat Pengajian Sains Fizik
Published: (2004)